These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9846181

  • 21. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J.
    Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999
    [Abstract] [Full Text] [Related]

  • 22. Vitamin D3 polyunsaturated side-chain analogues (EB1089, GS1590) and the 20-epi-vitamin D3 analogue CB1393 suppress parathyroid hormone secretion and mRNA level in bovine parathyroid cells.
    Segersten U, Holm PK, Binderup L, Akerström G, Hellman P, Westin G.
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):289-94. PubMed ID: 15120422
    [Abstract] [Full Text] [Related]

  • 23. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines.
    Opolski A, Wietrzyk J, Chrobak A, Marcinkowska E, Wojdat E, Kutner A, Radzikowski C.
    Anticancer Res; 1999 Mar; 19(6B):5217-22. PubMed ID: 10697538
    [Abstract] [Full Text] [Related]

  • 24. Studies on the influence of vitamin D3 metabolites on apoptosis induction in human neoplastic cells.
    Gruber BM, Anuszewska EL.
    Acta Pol Pharm; 2003 Mar; 60(5):363-6. PubMed ID: 15005419
    [Abstract] [Full Text] [Related]

  • 25. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H, Spinner D, Reddy GS, Lindley IJ.
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [Abstract] [Full Text] [Related]

  • 26. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
    Pérez-García X, Rumbo A, Larriba MJ, Ordóñez P, Muñoz A, Mouriño A.
    Org Lett; 2003 Oct 30; 5(22):4033-6. PubMed ID: 14572242
    [Abstract] [Full Text] [Related]

  • 27. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
    Chawla-Sarkar M, Leaman DW, Borden EC.
    Clin Cancer Res; 2001 Jun 30; 7(6):1821-31. PubMed ID: 11410525
    [Abstract] [Full Text] [Related]

  • 28. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
    Khanim FL, Gommersall LM, Wood VH, Smith KL, Montalvo L, O'Neill LP, Xu Y, Peehl DM, Stewart PM, Turner BM, Campbell MJ.
    Oncogene; 2004 Sep 02; 23(40):6712-25. PubMed ID: 15300237
    [Abstract] [Full Text] [Related]

  • 29. Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells.
    Bondza-Kibangou P, Millot C, El Khoury V, Millot JM.
    Oncol Rep; 2007 Dec 02; 18(6):1513-9. PubMed ID: 17982638
    [Abstract] [Full Text] [Related]

  • 30. [Regulatory mechanism of EB1089 for hepatocarcinoma cell proliferation].
    Luo W, Chen J, Zhang X, Wang W.
    Wei Sheng Yan Jiu; 2004 Mar 02; 33(2):140-3. PubMed ID: 15208989
    [Abstract] [Full Text] [Related]

  • 31. Retinoids and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line.
    Emionite L, Galmozzi F, Raffo P, Vergani L, Toma S.
    Anticancer Res; 2003 Mar 02; 23(1A):13-9. PubMed ID: 12680189
    [Abstract] [Full Text] [Related]

  • 32. Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells.
    Larsen SS, Heiberg I, Lykkesfeldt AE.
    Br J Cancer; 2001 Mar 02; 84(5):686-90. PubMed ID: 11237391
    [Abstract] [Full Text] [Related]

  • 33. Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.
    Facchetti F, Previdi S, Ballarini M, Minucci S, Perego P, La Porta CA.
    Apoptosis; 2004 Sep 02; 9(5):573-82. PubMed ID: 15314285
    [Abstract] [Full Text] [Related]

  • 34. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
    Valrance ME, Welsh J.
    J Steroid Biochem Mol Biol; 2004 May 02; 89-90(1-5):221-5. PubMed ID: 15225775
    [Abstract] [Full Text] [Related]

  • 35. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
    Zinser GM, McEleney K, Welsh J.
    Mol Cell Endocrinol; 2003 Feb 28; 200(1-2):67-80. PubMed ID: 12644300
    [Abstract] [Full Text] [Related]

  • 36. 1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2.
    Akhter J, Lu Y, Finlay I, Pourgholami MH, Morris DL.
    ANZ J Surg; 2001 Jul 28; 71(7):414-7. PubMed ID: 11450917
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The potent anti-proliferative effect of 20-epi analogues of 1,25 dihydroxyvitamin D3 in human breast-cancer MCF-7 cells is related to promoter selectivity.
    Mørk Hansen C, Danielsson C, Carlberg C.
    Int J Cancer; 1996 Sep 04; 67(5):739-42. PubMed ID: 8782667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.